Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Brooks, BR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 100 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bushara, KO; Wheat, JM; Khan, A; Mock, BJ; Turski, PA; Sorenson, J; Brooks, BR
      Multiple tactile maps in the human cerebellum

      NEUROREPORT
    2. Sanjak, M; Brinkmann, J; Belden, DS; Roelke, K; Waclawik, A; Neville, HE; Ringel, SP; Murphy, JR; Brooks, BR
      Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    3. Speelman, B; Brooks, BR; Post, CB
      Molecular dynamics simulations of human rhinovirus and an antiviral compound

      BIOPHYSICAL JOURNAL
    4. Brooks, BR; Sanjak, M; Belden, D; Waclawik, A
      Motor neurone disease: Basic designs, sample sizes and pitfalls

      CLINICAL TRIALS IN NEUROLOGY
    5. Brooks, BR; Miller, RG; Swash, M; Munsat, TL
      El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    6. Brooks, BR; Juhasz-Poscine, K; Waclawik, A; Sanjak, M; Belden, D; Roelke, K; Parnell, J; Weasler, C
      Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    7. Brooks, BR; Bushara, K; Khan, A; Hershberger, J; Wheat, JO; Belden, D; Henningsen, H
      Functional magnetic resonance imaging (fMRI) clinical studies in ALS - paradigms, problems and promises

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    8. Brooks, BR
      Debating the possibility of earlier diagnosis of patients with amyotrophiclateral sclerosis

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    9. Brooks, BR
      Risk factors in the early diagnosis of ALS: North American epidemiologicalstudies

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    10. Brooks, BR
      Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    11. Johnson, KP; Brooks, BR; Ford, CC; Goodman, A; Guarnaccia, J; Lisak, RP; Myers, LW; Panitch, HS; Pruitt, A; Rose, JW; Kachuck, N; Wolinsky, JS
      Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

      MULTIPLE SCLEROSIS
    12. Miller, RG; Anderson, FA; Bradley, WG; Brooks, BR; Mitsumoto, H; Munsat, TL; Ringel, SP
      The ALS Patient Care Database - Goals, design, and early results

      NEUROLOGY
    13. Szurek, PF; Brooks, BR
      Synthesis of virus-specific high-mobility DNA after temperature upshift ofSC-1 cells chronically infected with moloney murine leukemia virus mutant ts1

      JOURNAL OF VIROLOGY
    14. Zhou, J; Reich, S; Brooks, BR
      Elastic molecular dynamics with self-consistent flexible constraints

      JOURNAL OF CHEMICAL PHYSICS
    15. Venable, RM; Brooks, BR; Pastor, RW
      Molecular dynamics simulations of gel (L-beta I) phase lipid bilayers in constant pressure and constant surface area ensembles

      JOURNAL OF CHEMICAL PHYSICS
    16. Waclawik, AJ; Vann, J; Schmelz, G; Szurek, P; Lewandoski, P; Brooks, BR
      Zidovudine [AZT] myotoxicity: Quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus

      NEUROTOXICOLOGY
    17. Miller, RG; Rosenberg, JA; Gelinas, DF; Mitsumoto, H; Newman, D; Sufit, R; Borasio, GD; Bradley, WG; Bromberg, MB; Brooks, BR; Kasarskis, EJ; Munsat, TL; Oppenheimer, EA
      Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review)

      MUSCLE & NERVE
    18. Brooks, BR
      Defining optimal management in ALS: from first symptoms to announcement - Introduction

      NEUROLOGY
    19. Brooks, BR
      What are the implications of early diagnosis? Maintaining optimal health as long as possible

      NEUROLOGY
    20. Brooks, BR
      Earlier is better: the benefits of early diagnosis

      NEUROLOGY
    21. Brooks, BR
      Closing remarks

      NEUROLOGY
    22. Miller, RG; Rosenberg, JA; Gelinas, NF; Mitsumoto, H; Newman, D; Sufit, R; Borasio, GD; Bradley, WG; Bromberg, MB; Brooks, BR; Kasarskis, EJ; Munsat, TL; Oppenheimer, EA
      Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology

      NEUROLOGY
    23. Kasarskis, EJ; Shefner, JM; Miller, R; Smith, RA; Licht, J; Mitsumoto, H; Hopkins, LC; Rosenfeld, J; Pascuzzi, R; Cornblath, DR; Armon, C; Strong, MJ; Kula, R; Windebank, A; Bosch, EP; Smith, BE; Cashman, N; Sivak, M; Sergay, S; Siddique, T; Sufit, RL; Johnston, W; Brooke, MB; Graves, MC; Olney, RK; Roos, RP; Neville, H; Ringel, SP; Ross, M; Bradley, WG; Sharma, KR; Parry, G; Mandler, R; Giuliani, M; Thornton, CA; Jackson, C; Bryan, W; Bromberg, M; Tandan, R; Fries, T; Phillips, L; Brooks, BR; Fenichel, G; Pestronk, A; Bear, M; Beatey, R; Fuller, C; Hill, R; Malta, E; Nakanishi, A; Patel, A; Thurmond, B; Cedarbaum, JM; Stambler, N
      A controlled trial of recombinant methionyl human BDNF in ALS

      NEUROLOGY
    24. Miller, RG; Munsat, TL; Swash, M; Brooks, BR
      Consensus guidelines far the design and implementation of clinical trials in ALS

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    25. Brooks, BR
      Diagnostic dilemmas in amyotrophic lateral sclerosis

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    26. CHEATHAM TE; BROOKS BR
      RECENT ADVANCES IN MOLECULAR-DYNAMICS SIMULATION TOWARDS THE REALISTIC REPRESENTATION OF BIOMOLECULES IN SOLUTION

      Theoretical Chemistry accounts ( Theoretical Chemistry accounts (Print))
    27. Ford, CC; Brooks, BR; Johnson, KP; Lisak, RP; Myers, LW; Panitch, HS; Rose, JW; Schiffer, RB; Vollmer, T; Weiner, LP; Wolinsky, JS
      Sustained efficacy of glatiramer acetate for injection in a 5+ year trial of relapsing remitting MS

      MULTIPLE SCLEROSIS
    28. CEDARBAUM JM; STAMBLER N; BROOKS BR; BRADLEY W
      BRAIN-DERIVED NEUROTROPHIC FACTOR IN AMYOTROPHIC-LATERAL-SCLEROSIS - A FAILED DRUG OR A FAILED TRIAL

      Annals of neurology
    29. LEE YS; HODOSCEK M; BROOKS BR; KADOR PF
      CATALYTIC MECHANISM OF ALDOSE REDUCTASE STUDIED BY THE COMBINED POTENTIALS OF QUANTUM-MECHANICS AND MOLECULAR MECHANICS

      Biophysical chemistry
    30. CHATFIELD DC; EURENIUS KP; BROOKS BR
      HIV-1 PROTEASE CLEAVAGE MECHANISM - A THEORETICAL INVESTIGATION BASEDON CLASSICAL MD SIMULATION AND REACTION-PATH CALCULATIONS USING A HYBRID QM MM POTENTIAL/

      Journal of molecular structure. Theochem
    31. SIDDIQUE T; HONG S; BROOKS BR; HUNG WY; SIDDIQUE NA; RIMMLER J; KAPLAN JP; HAINES JL; BROWN RH; PERICAK MA
      X-LINKED DOMINANT ALS

      Neurology
    32. DIXIT SN; DOGAN S; BROOKS BR
      COMPUTERIZED TREMOR TESTING IN MULTIPLE-SCLEROSIS [MS] - TREMOR PREVALENCE, TYPE, LONGITUDINAL EVOLUTION AND RESPONSE TO TREATMENT IN 185 PATIENTS

      Neurology
    33. KHAN A; FERNANDEZSCHMIDT D; BUSHARA K; BALDEN DS; MOCK B; SORENSON J; TURSKI P; BROOKS BR
      DIFFERENTIAL SENSORIMOTOR CORTEX (SMC) ACTIVATION FOLLOWING CUTANEOUSSTIMULATION OF THE HAND AND FOOT IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - THE EFFECT OF THE BABINSKI RESPONSE - A FUNCTIONAL MAGNETIC-RESONANCE-IMAGING (FMRI) STUDY

      Neurology
    34. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS
      EXTENDED USE OF GLATIRAMER ACETATE (COPAXONE) IS WELL TOLERATED AND MAINTAINS ITS CLINICAL EFFECT ON MULTIPLE-SCLEROSIS RELAPSE RATE AND DEGREE OF DISABILITY

      Neurology
    35. BOGUSZ S; CHEATHAM TE; BROOKS BR
      REMOVAL OF PRESSURE AND FREE-ENERGY ARTIFACTS IN CHARGED PERIODIC-SYSTEMS VIA NET CHARGE CORRECTIONS TO THE EWALD POTENTIAL

      The Journal of chemical physics
    36. ENYEDY IJ; KOVACH IM; BROOKS BR
      ALTERNATE PATHWAYS FOR ACETIC-ACID AND ACETATE ION RELEASE FROM ACETYLCHOLINESTERASE - A MOLECULAR-DYNAMICS STUDY

      Journal of the American Chemical Society
    37. CHATFIELD DC; SZABO A; BROOKS BR
      MOLECULAR-DYNAMICS OF STAPHYLOCOCCAL NUCLEASE - COMPARISON OF SIMULATION WITH N-15 AND C-13 NMR RELAXATION DATA

      Journal of the American Chemical Society
    38. LIU Y; BROOKS BR; TANIGUCHI N; HARTMANN HA
      CUZNSOD AND MNSOD IMMUNOREACTIVITY IN BRAIN-STEM MOTOR-NEURONS FROM AMYOTROPIC LATERAL SCLEROSIS PATIENTS

      Acta Neuropathologica
    39. BUSHARA KO; WHEAT JM; MOCK BJ; BELDEN DS; HENNINGSEN H; CORDES D; BERNSTEIN Z; SORENSON JA; TURSKI PA; BROOKS BR
      SOMATOSENSORY REPRESENTATION OF THE HAND IN 2 SEPARATE AREAS OF THE HUMAN CEREBELLUM

      Annals of neurology
    40. BROOKS BR; SHODIS KA; LOTTO M; SANJAK M; ROELKE K; BELDEN D; PARNELL J; DEWITT C; WHEAT K
      ECONOMIC-DEPENDENT, CAREGIVER-DEPENDENT, AND VENTILATOR-DEPENDENT STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS - PROSPECTIVE CORRELATION WITH ALS FUNCTIONAL RATING-SCALE, ISOMETRIC MUSCLE STRENGTH, PULMONARY-FUNCTION, SF-36, AND SICKNESS IMPACT PROFILE QUALITY-OF-LIFE MEASURES

      Annals of neurology
    41. PARRY CS; BROOKS BR; MATSUNAGA N; AMZEL LM
      STRUCTURES OF SOME SUBSTITUTED NITROPHENOLS DETERMINED BY AB-INITIO COMPUTATION - ON THE ORIGIN OF HETEROCLITICITY IN ANTI-NITROPHENOL ANTIBODIES

      Journal of molecular structure. Theochem
    42. FADIC R; WACLAWIK AJ; BROOKS BR; LOTZ BP
      THE RIGID SPINE SYNDROME DUE TO ACID MALTASE DEFICIENCY

      Muscle & nerve
    43. JUHASZPOCSINE K; WACLAWIK AJ; GLINSKI L; DENG HX; KAPLAN J; CALIENDO J; SIDDIQUE T; BROOKS BR
      CLINICOPATHOLOGICAL PHENOTYPE OF FAMILIAL ALS WITH A NOVEL EXON-4 CODON-100 SOD1 GENE MUTATION IN AN AFRO-AMERICAN FAMILY

      Neurology
    44. WACLAWIK AJ; LOTZ BP; SALAMAT SM; BEINLICH BR; BROOKS BR
      MYOPATHIC DROPPED HEAD SYNDROME - AN EXPANDING CLINICOPATHOLOGICAL SPECTRUM

      Neurology
    45. BUSHARA KO; HENNINGSEN H; WHEAT JM; MOCK BJ; LOWE MJ; TURSKI PA; SORENSEN JA; BROOKS BR
      DECREASED CORTICAL ACTIVATION DURING SENSORY STIMULATION IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - A FUNCTIONAL MAGNETIC-RESONANCE (FMRI) STUDY

      Neurology
    46. WACLAWIK AJ; LOTZ BP; BEINLICH BR; BROOKS BR
      DROPPED HEAD SYNDROME

      Neurology
    47. STEINBACH PJ; BROOKS BR
      DYNAMICS OF MYOGLOBIN IN SOLUTION SIMULATED AT MULTIPLE TEMPERATURES

      Biophysical journal
    48. BROOKS BR
      EMERGING DIRECTIONS IN ALS THERAPEUTICS - PALLIATIVE THERAPIES AT THEADVENT OF THE 21ST-CENTURY

      Clinical neuroscience
    49. BHATTACHARYYA D; BROOKS BR; CALLAHAN L
      POSITIONING OF POSITIVELY CHARGED RESIDUES IN THE V3 LOOP CORRELATES WITH HIV TYPE-1 SYNCYTIUM-INDUCING PHENOTYPE

      AIDS research and human retroviruses
    50. BROOKS BR
      CLINICAL EPIDEMIOLOGY OF AMYOTROPHIC-LATERAL-SCLEROSIS

      Neurologic clinics
    51. STRONG M; ROTHSTEIN JD; FELDMAN E; CLEVELAND D; BROOKS BR
      EXCITOTOXICITY HYPOTHESIS - DISCUSSION

      Neurology
    52. MITSUMOTO H; SMITH RG; DRACHMAN D; BROOKS BR
      AUTOIMMUNITY AND ALS - DISCUSSION

      Neurology
    53. BROOKS BR
      NATURAL-HISTORY OF ALS - SYMPTOMS, STRENGTH, PULMONARY-FUNCTION, AND DISABILITY

      Neurology
    54. MITSUMOTO H; BROOKS BR; HAVERKAMP L; MILLER RG
      NATURAL-HISTORY OF ALS - SYMPTOMS, STRENGTH, PULMONARY-FUNCTION, AND DISABILITY - DISCUSSION

      Neurology
    55. GUTMAN L; MUNSAT TL; HAVERKAMP L; BROOKS BR; JOHNSTON W
      DEVELOPMENT OF MEASUREMENT TECHNIQUES - DISCUSSION

      Neurology
    56. BROMBERG MB; BROOKS BR
      ISSUES IN CLINICAL-TRIAL DESIGN .2. SELECTION OF END-POINT MEASURES

      Neurology
    57. GUTMANN L; DRACHMAN D; MUNSAT TL; BROOKE MH; LAI E; MILLER RG; GAWEL M; SUMNER AJ; MITSUMOTO H; BROOKS BR; GELINAS D; JOHNSTON W
      COMMUNICATIONS AND ALS TRIAL - INFORMATION SHARING

      Neurology
    58. HERSHBERGER JE; BROOKS BR; LOWE MJ; MOCK BJ; WANG X; TURSKI PA; SORENSEN JA; BERNSTEIN Z
      EVALUATION OF UPPER MOTOR-NEURON PHYSIOLOGICAL TESTS FOR FUNCTIONAL MAGNETIC-RESONANCE-IMAGING ASSESSMENT OF CORTICAL ACTIVATION PATTERNS IN AMYOTROPHIC-LATERAL-SCLEROSIS - DEVELOPMENT OF TEST PARADIGMS FOR LONGITUDINAL-STUDIES

      Neurology
    59. BROOKS BR
      PROGNOSTIC INDICATORS OF SURVIVAL IN AMYOTROPHIC-LATERAL-SCLEROSIS

      Neurology
    60. DIXIT S; BUSHARA K; BROOKS BR
      EPIDEMIC HEAT-STROKE IN A MIDWEST COMMUNITY - RISK-FACTORS, NEUROLOGIC COMPLICATIONS, AND SEQUELAE

      Neurology
    61. STEINBACH PJ; BROOKS BR
      HYDRATED MYOGLOBINS ANHARMONIC FLUCTUATIONS ARE NOT PRIMARILY DUE TO DIHEDRAL TRANSITIONS

      Proceedings of the National Academy of Sciences of the United Statesof America
    62. SZUREK PF; BROOKS BR
      TS1-INDUCED SPONGIFORM ENCEPHALOMYELOPATHY - PHYSICAL FORMS OF HIGH-MOBILITY DNA IN SPINAL-CORD TISSUES OF PARALYZED MICE ARE PRODUCTS OF PREMATURE TERMINATION OF REVERSE TRANSCRIPTION

      Journal of virology
    63. FELLER SE; PASTOR RW; ROJNUCKARIN A; BOGUSZ S; BROOKS BR
      EFFECT OF ELECTROSTATIC FORCE TRUNCATION ON INTERFACIAL AND TRANSPORT-PROPERTIES OF WATER

      Journal of physical chemistry
    64. EURENIUS KP; CHATFIELD DC; BROOKS BR; HODOSCEK M
      ENZYME MECHANISMS WITH HYBRID QUANTUM AND MOLECULAR MECHANICAL POTENTIALS .1. THEORETICAL CONSIDERATIONS

      International journal of quantum chemistry
    65. FINISON LJ; BROOKS BR; RINGEL SP; MUNSAT TL; NEVILLE HE; MURPHY JR; ENGLAND JD; LEE JY; BRINKMANN JR; ZITER F; ALDERSON MK; PETAJAN JH; GAPPMAIER E; MYLAR D; BRYAN W; HERBELIN J; SMITH P; MILLER RG; ALMADA A; MENDOZA M; YU P; ROELOFS RI; SMITH SA; GRAVES J; SUFIT RL; SANJAK M; COOK T; JUBELT B; HELLER S; CASEY P; ROOS R; SALESARGRUSEO E; RICHMOND I; ANDRES PL; HEDLUND W
      MUSCULAR WEAKNESS ASSESSMENT - USE OF NORMAL ISOMETRIC STRENGTH DATA

      Archives of physical medicine and rehabilitation
    66. BROOKS BR; SANJAK M; RINGEL S; ENGLAND J; BRINKMANN J; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; WITTES J; CHARATAN M; STAMBLER N; CEDARBAUM JM
      THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE - ASSESSMENT OF ACTIVITIES OF DAILY LIVING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS

      Archives of neurology
    67. WACLAWIK AJ; FADIC R; LOTZ BP; BEINLICH BR; LEWANDOSKI PJ; SANJAK M; BROOKS BR
      CD8 AND CD4 T-CELL-MEDIATED POLYMYOSITIS COMPLICATING THE HTLV-1 ASSOCIATED MYELOPATHY - QUANTITATIVE-EVALUATION OF CORTICOSTEROID TREATMENT

      Acta neurologica Scandinavica
    68. LANDAU WM; DAUBE JR; AMINOFF MJ; BREY RL; BROOKS BR; DEUEL RK; GALABURDA AM; PORTER JA; ROSENBAUM RB; WHITHAM RH; WIGGS JW
      NEUROREALITY .1. DEDICATED DEMOLITION OF THE DECADE OF THE BRAIN - THE GENUINE THREAT TO NEUROLOGIC RESEARCH FROM THE ANIMAL RADICAL RIGHT

      Journal of child neurology
    69. BROOKS BR; SHODIS KA; SANJAK M; BELDEN D
      TEMPORAL DISTINCTION OF SPINAL AND BULBAR STAGES OF AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) - VALIDATION WITH TIME-TO-FAILURE ANALYSIS EMPLOYING ALS FUNCTIONAL RATING-SCALE

      Annals of neurology
    70. VANN JM; GOLDMAN AJ; SZUREK PF; BROOKS BR
      DEOXYGLUCOSE UPTAKE BY MOUSE ASTROCYTES - EFFECTS OF TEMPERATURE AND RETROVIRUS INFECTION

      Neurochemical research
    71. CEDARBAUM JM; CHAPMAN C; CHARATAN M; STAMBLER N; ANDREWS L; ZHAN C; RADKA S; MORRISEY D; LAKINGS D; BROOKS BR; SANJAK M; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; BITTLE L; RINGEL S; NEVILLE H; BRINKMANN J
      THE PHARMACOKINETICS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMANCILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - RELATION TO PARAMETERS OF THE ACUTE-PHASE RESPONSE

      Clinical neuropharmacology
    72. CEDARBAUM JM; CHAPMAN C; CHARATAN M; STAMBLER N; ANDREWS L; ZHAN C; RADKA S; MORRISEY D; LAKINGS D; BROOKS BR; SANJAK M; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; BITTLE L; NEVILLE H; RINGEL S; BRINKMANN J; WITTES J
      A PHASE-I STUDY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS

      Clinical neuropharmacology
    73. BROOKS BR; JANEZIC D; KARPLUS M
      HARMONIC-ANALYSIS OF LARGE SYSTEMS .1. METHODOLOGY

      Journal of computational chemistry
    74. JANEZIC D; BROOKS BR
      HARMONIC-ANALYSIS OF LARGE SYSTEMS .2. COMPARISON OF DIFFERENT PROTEIN MODELS

      Journal of computational chemistry
    75. JANEZIC D; VENABLE RM; BROOKS BR
      HARMONIC-ANALYSIS OF LARGE SYSTEMS .3. COMPARISON WITH MOLECULAR-DYNAMICS

      Journal of computational chemistry
    76. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS; BIRD SJ; CONSTANTINESCU C; KOLSON DL; GONZALEZSCARANO F; BRENNAN D; PFOHL D; MANDLER RN; ROSENBERG GA; JEFFREY C; BARGER GR; GANDHI B; MOORE PM; ROGERS LR; LISAK D; SMITH L; ELLISON GW; BAUMHEFNER RW; CRAIG SL; JALBUT SS; KATZ E; CONWAY KL; BURNS JB; SHIBA C; GIANG DW; PETRIE MD; GUARNACCIA JB; ANDERSON S; MCKEON A; MCCARTHY M; THOMAS AB; VRIESENDORP FJ; AUSTIN SG; LINDSEY JW; DIMACHKIE M; CERRETA E; KACHUCK N; MCCARTHY KA; FLEMING J; PARNELL JH; TAMULEVICH J; WEASLER C; KADOSH S; HALT H; STARK Y; PINCHASI I; SPILLER N; VANDENNOORT S; MILLER A; MELLITS D; HOPKINS J; REINGOLD S; GOMOLIN IH
      COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      Neurology
    77. SZUREK P; BROOKS BR
      ENVELOPE GENE ILE25 LOCUS IN TS1 NEUROPATHOGENIC RETROVIRUS-INDUCED SPONGIFORM POLIOENCEPHALOMYELOPATHY DETERMINES ONSET LATENCY OF DISEASEAND APPEARANCE OF NOVEL LOW-MOLECULAR-WEIGHT VIRAL-DNA FORMS INDICATIVE OF INFECTION OF QUIESCENT CNS CELLS

      Neurology
    78. BROOKS BR
      PHASE-II-III DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS

      Neurology
    79. LANDAU WM; DAUBE JR; AMINOFF MJ; BREY RL; BROOKS BR; DEUEL RK; GALABURDA AM; PORTER JA; ROSENBAUM RB; WHITHAM RH; WIGGS JW
      NEUROREALITY .1. DEDICATED DEMOLITION OF THE DECADE OF THE BRAIN - THE GENUINE THREAT TO NEUROLOGIC RESEARCH FROM THE ANIMAL RADICAL RIGHT

      Neurology
    80. SZUREK PF; BROOKS BR
      DEVELOPMENT OF PHYSICAL FORMS OF UNINTEGRATED RETROVIRAL DNA IN MOUSESPINAL-CORD TISSUE DURING TS1-INDUCED SPONGIFORM ENCEPHALOMYELOPATHY - ELEVATED LEVELS OF A NOVEL SINGLE-STRANDED FORM IN PARALYZED MICE

      Journal of virology
    81. ZHANG YH; FELLER SE; BROOKS BR; PASTOR RW
      COMPUTER-SIMULATION OF LIQUID LIQUID INTERFACES .1. THEORY AND APPLICATION TO OCTANE/WATER/

      The Journal of chemical physics
    82. FELLER SE; ZHANG YH; PASTOR RW; BROOKS BR
      CONSTANT-PRESSURE MOLECULAR-DYNAMICS SIMULATION - THE LANGEVIN PISTONMETHOD

      The Journal of chemical physics
    83. CHATFIELD DC; BROOKS BR
      HIV-1 PROTEASE CLEAVAGE MECHANISM ELUCIDATED WITH MOLECULAR-DYNAMICS SIMULATION

      Journal of the American Chemical Society
    84. BROOKS BR; SANJAK M; BELDEN D
      QUANTITATIVE NATURAL-HISTORY OF ISOMETRIC STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS AND MULTIPLE-SCLEROSIS - MEGASLOPES NORMALIZED TO A GENDER-SPECIFIED AND AGE-SPECIFIED NORMAL SUBJECT POPULATION DEMONSTRATE GENDER-SPECIFIC REGIONAL DIFFERENCES IN THE COURSE OF AMYOTROPHIC-LATERAL-SCLEROSIS COMPARED WITH MULTIPLE-SCLEROSIS

      Annals of neurology
    85. STEINBACH PJ; BROOKS BR
      NEW SPHERICAL-CUTOFF METHODS FOR LONG-RANGE FORCES IN MACROMOLECULAR SIMULATION

      Journal of computational chemistry
    86. TULUNAYKEESEY U; BROOKS BR; KUKUJAN R; HOEVE JNV
      EFFECT OF ORIENTATION ON SPATIOTEMPORAL CONTRAST SENSITIVITY IN MULTIPLE-SCLEROSIS

      Vision research
    87. BROOKS BR; SANJAK M; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; WITTES J; BRITTAIN E; STAMBLER N; CHARATAN M; CHAPMAN C; CEDARBAUM JM
      ANALYZING THE EFFECT OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR(RHCNTF) ON MUSCLE STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)

      Neurology
    88. CEDARBAUM JM; WITTES J; BRITTAIN E; BROOKS BR; SANJAK M; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; MITSUMOTO H; SZIRONY K; STAMBLER N; CHARATAN M; CHAPMAN C
      CORRELATION BETWEEN RATES OF CHANGE IN FUNCTIONAL RATING-SCALES AND MUSCLE STRENGTH MEASURES IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS

      Neurology
    89. VANN J; GOLDMAN AJ; SZUREK P; BROOKS BR
      REGION-SPECIFIC ALTERATIONS IN MOUSE ASTROCYTE ATP CONTENT INDUCED BYNEUROPATHOGENIC TS1 MUTANT OF MOLONEY LEUKEMIA-VIRUS INFECTION IN-VITRO

      Neurology
    90. SZUREK P; BROOKS BR
      RETROVIRAL ENVELOPE (ENV)-SPECIFIC VIRAL-DNA FORMS IN TS1-INDUCED SPONGIFORM POLIOENCEPHALOMYELOPATHY - NEW LOW-MOLECULAR-WEIGHT VIRAL-DNA FORM OCCURS WITH THE APPEARANCE OF CLINICAL-DISEASE

      Neurology
    91. BROOKS BR
      EL-ESCORIAL WORLD FEDERATION OF NEUROLOGY CRITERIA FOR THE DIAGNOSIS OF AMYOTROPHIC-LATERAL-SCLEROSIS

      Journal of the neurological sciences
    92. DURELL SR; BROOKS BR; BENNAIM A
      SOLVENT-INDUCED FORCES BETWEEN 2 HYDROPHILIC GROUPS

      Journal of physical chemistry
    93. STEINBACH PJ; BROOKS BR
      PROTEIN SIMULATION BELOW THE GLASS-TRANSITION TEMPERATURE - DEPENDENCE ON COOLING PROTOCOL

      Chemical physics letters
    94. STEINBACH PJ; BROOKS BR
      THE GLASS-TRANSITION IN MYOGLOBIN

      Biophysical journal
    95. BROOKS BR; LEWIS D; RAWLING J; SANJAK M; BELDEN D; HAKIM H; DETAN Y; SUFIT RL; GAFFNEY J; DEPAUL R
      NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS - EFFECT OF SITE OF ONSET AND TIME AFTER ONSET ON SAMPLE-SIZE CALCULATIONS FOR CLINICAL THERAPEUTIC TRIALS EMPLOYING SLOPE OF STRENGTH LOSS

      Annals of neurology
    96. LEWIS DH; BELDEN D; RAWLING J; CAREY P; SANJAK M; BROOKS BR
      STATISTICAL-ANALYSIS OF STRENGTH AND FUNCTION IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)

      Neurology
    97. BROOKS BR; SANJAK M; MITSUMOTO H; SZIRONY K; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; CEDARBAUM JM; CHARATAN M; STAMBLER N; WITTES J; BRITTAIN E
      RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES

      Neurology
    98. CEDARBAUM JM; CHARATAN M; STAMBLER N; BROOKS BR; SANJAK M; MITSUMOTO WH; SZIRONY K; NEVILLE H; RINGEL S; BRINKMANN J; PESTRONK A; FLORENCE J; WITTES J; BRITTAIN E
      THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE (ALSFRS) - PROSPECTIVE VALIDATION AND CHANGES OVER TIME

      Neurology
    99. STEINBACH PJ; BROOKS BR
      PROTEIN HYDRATION ELUCIDATED BY MOLECULAR-DYNAMICS SIMULATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    100. DEPAUL R; BROOKS BR
      MULTIPLE OROFACIAL INDEXES IN AMYOTROPHIC-LATERAL-SCLEROSIS

      Journal of speech and hearing research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 07:42:42